Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Net Income towards Common Stockholders: 2015-2024

Historic Net Income towards Common Stockholders for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to -$145.2 million.

  • Anaptysbio's Net Income towards Common Stockholders rose 146.00% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year increase of 48.91%. This contributed to the annual value of -$145.2 million for FY2024, which is 11.24% up from last year.
  • As of FY2024, Anaptysbio's Net Income towards Common Stockholders stood at -$145.2 million, which was up 11.24% from -$163.6 million recorded in FY2023.
  • In the past 5 years, Anaptysbio's Net Income towards Common Stockholders ranged from a high of -$19.9 million in FY2020 and a low of -$163.6 million during FY2023.
  • For the 3-year period, Anaptysbio's Net Income towards Common Stockholders averaged around -$145.9 million, with its median value being -$145.2 million (2024).
  • Per our database at Business Quant, Anaptysbio's Net Income towards Common Stockholders soared by 79.52% in 2020 and then tumbled by 189.98% in 2021.
  • Anaptysbio's Net Income towards Common Stockholders (Yearly) stood at -$19.9 million in 2020, then crashed by 189.98% to -$57.8 million in 2021, then tumbled by 122.72% to -$128.7 million in 2022, then fell by 27.11% to -$163.6 million in 2023, then rose by 11.24% to -$145.2 million in 2024.